On the upside
Zix (Nasdaq: ZIXI) offered an upbeat preliminary fourth quarter update and announced that it expects 2010 to be its first profitable year.
Cyclacel Pharmaceuticals (Nasdaq: CYCC) reported that its lung cancer treatment seliciclib killed lung cancer cells.
Somaxon Pharmaceuticals (Nasdaq: SOMX) reassured investors that it will continue working with the Food and Drug Administration in seeking approval of its insomnia medication Silenor.
On the downside
ZymoGenetics (Nasdaq: ZGEN) increased its public offering to 14 million common shares at $6 per share.
J.C. Penney (NYSE: JCP) reported a drop in December same store sales.
Analysts downgraded Hot Topic (Nasdaq: HOTT) after the teen apparel retailer reported lower December same store sales and cut its fourth quarter guidance.
In the broad market, declining issues barely edged out advancers by a slim margin on both the NYSE and on Nasdaq. The Russell 2000 which tracks small cap stocks eased a fraction to 637.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here